| Georgiana Nuss, MD | |
|
2400 W 49th St, Sioux Falls, SD 57105 | |
| (605) 312-8700 | |
| Not Available |
| Full Name | Georgiana Nuss |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 10 Years |
| Location | 2400 W 49th St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023428505 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Usd Medical Center | Sioux falls, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center | 8325950215 | 707 |
News Archive
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
Atritech, Inc., an emerging medical device company, announced today that it has obtained clarity from the U.S. Food and Drug Agency on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage Closure Technology in the United States.
› Verified 2 days ago
| Entity Name | Sanford Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396764254 PECOS PAC ID: 0244143824 Enrollment ID: O20031110000532 |
News Archive
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
Atritech, Inc., an emerging medical device company, announced today that it has obtained clarity from the U.S. Food and Drug Agency on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage Closure Technology in the United States.
› Verified 2 days ago
| Entity Name | Sanford Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
Atritech, Inc., an emerging medical device company, announced today that it has obtained clarity from the U.S. Food and Drug Agency on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage Closure Technology in the United States.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Georgiana Nuss, MD 611 Par Tee Dr, Hartford, SD 57033-2340 Ph: () - | Georgiana Nuss, MD 2400 W 49th St, Sioux Falls, SD 57105 Ph: (605) 312-8700 |
News Archive
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
Atritech, Inc., an emerging medical device company, announced today that it has obtained clarity from the U.S. Food and Drug Agency on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage Closure Technology in the United States.
› Verified 2 days ago
Dr. Alex James Linn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave Ste 610, Sioux Falls, SD 57105 Phone: 605-322-8860 Fax: 605-322-8868 | |
Amber Olson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Sioux Falls, SD 57108 Phone: 605-322-4005 | |
Dr. Robert Floyd Nuss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W. 69th St., Ste. 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 | |
Sarah A Flynn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 Fax: 605-322-5704 | |
Mackenzie Mertz, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 W 49th St, Sioux Falls, SD 57105 Phone: 605-312-8700 | |
Hannah Statz Devries, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 |